Back Home Search

Extensive SCLC

    • Protocols
    • UW22022

      OPEN TO ACCRUAL

      Phase II Randomized Trial of Temozolomide and Atezolizumab as Second or ThirdLine Treatment for SCLC

    • UW23030

      OPEN TO ACCRUAL

      DARES

    • UW23047

      OPEN TO ACCRUAL

      Ph 3 Atezolizumab-Controlled Study of HLX10 + Chemo (Carboplatin-Etoposide) in Patients with ES-SCLC